---
title: "ATYR: Efzofitimod advances toward approval with a new phase III trial targeting restrictive sarcoidosis"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290879435.md"
description: "Revised summary:Efzofitimod showed quality of life improvements and a strong safety profile in pulmonary sarcoidosis, despite missing the primary steroid reduction endpoint. The next phase III trial will target a sicker population with forced vital capacity as the primary endpoint, aiming for approval and expansion to other interstitial lung diseases.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-06-25T20:55:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290879435.md)
  - [en](https://longbridge.com/en/news/290879435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290879435.md)
generator: "portal-rs"
---

# ATYR: Efzofitimod advances toward approval with a new phase III trial targeting restrictive sarcoidosis

Revised summary:  
Efzofitimod showed quality of life improvements and a strong safety profile in pulmonary sarcoidosis, despite missing the primary steroid reduction endpoint. The next phase III trial will target a sicker population with forced vital capacity as the primary endpoint, aiming for approval and expansion to other interstitial lung diseases.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ATYR.US](https://longbridge.com/en/quote/ATYR.US.md)

## Related News & Research

- [aTyr Pharma expects FDA response by mid-September on efzofitimod Phase 3 sarcoidosis protocol](https://longbridge.com/en/news/297696098.md)
- [aTyr Pharma submits Phase 3 efzofitimod trial protocol to FDA for pulmonary sarcoidosis study](https://longbridge.com/en/news/295273060.md)
- [Hikers 'relied too much' on AI and had to be rescued. A ranger says it wasn't the first AI-related mishap he's seen.](https://longbridge.com/en/news/298103029.md)
- [Liquidia launches Phase 3 Re-Spire trial of L606 inhaled treprostinil in PH-ILD](https://longbridge.com/en/news/297786781.md)
- [Jensen Huang Says AI Is a 'Five-Layer Cake.' Nvidia Is Just One Slice](https://longbridge.com/en/news/297932347.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**